{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:56:16Z","timestamp":1740135376687,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neonatal hypoglycaemia is one of the major metabolic disorders that causes irreversible brain injury. Assessing for maternal glucose metabolism disorders can predict and avoid this perinatal complication. Accordingly, diagnosing maternal gestational diabetes mellitus (GDM) is important in protecting neonatal neurological prognosis. However, there are various methods of screening for maternal GDM. The intervention for neonatal hypoglycaemia also varies within each guideline.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A female infant was born at 37\u00a0weeks of gestation by vaginal delivery with no asphyxia. Her mother had no abnormal findings, including glucose metabolism disorders, upon periodic prenatal visits. Upon routine examination at the first hour of life, the baby was lethargic, pale, hypotonic, and rarely cried. An emergent systemic evaluation was performed, and she was diagnosed with severe hyperinsulinemic hypoglycaemia with blood glucose of 11\u00a0mg\/dL and insulin of 2.7 \u00b5U\/mL. She was soon fed with milk and her symptoms of hypoglycaemia was resolved before receiving intravenous glucose infusion. Her blood glucose level reached 78\u00a0mg\/dL 3\u00a0h after delivery. She was discharged home with her mother on day 6 of age without relapse of hypoglycaemia. Upon review, we determined that the mother was diagnosed with GDM during her previous pregnancy but not during this current pregnancy. The infant had no developmental delay upon check-up at 6\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The infant of this case was not a candidate for neonatal hypoglycaemia screening since her mother had no identifiable risk factors. This case suggests that previous maternal history of GDM might be the cause of neonatal hyperinsulinemic hypoglycaemia. Clinicians need to be aware of the possibility of hypoglycaemia among newborns with a maternal previous history of GDM, regardless of the mother\u2019s current diagnosis. Immediate oral feeding can be one of the treatments, even for symptomatic neonatal severe hypoglycaemia, when rapid intravenous access is difficult. The present case also suggests the necessity of considering neonatal outcomes as well as maternal ones when screening for maternal disorders of glucose metabolism.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-04763-3","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T16:04:57Z","timestamp":1652976297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of severe neonatal transient hyperinsulinemic hypoglycaemia without identifiable risk factors: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Asami","family":"Osada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6621-4237","authenticated-orcid":false,"given":"Takeshi","family":"Arimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"Kusakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takane","family":"Kin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Hida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"4763_CR1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026028","author":"TA Hillier","year":"2021","unstructured":"Hillier TA, Pedula KL, Ogasawara KK, Vesco KK, Oshiro CES, Lubarsky SL, et al. A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med. 2021. https:\/\/doi.org\/10.1056\/NEJMoa2026028.","journal-title":"N Engl J Med"},{"key":"4763_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2017.05.028","author":"G Mahajan","year":"2017","unstructured":"Mahajan G, Mukhopadhyay K, Attri S, Kumar P. Neurodevelopmental outcome of asymptomatic hypoglycemia compared with symptomatic hypoglycemia and euglycemia in high-risk neonates. Pediatr Neurol. 2017. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.05.028.","journal-title":"Pediatr Neurol"},{"key":"4763_CR3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2822","author":"CM Burns","year":"2008","unstructured":"Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics. 2008. https:\/\/doi.org\/10.1542\/peds.2007-2822.","journal-title":"Pediatrics"},{"key":"4763_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.580642","author":"M Roeper","year":"2020","unstructured":"Roeper M, Salimi Dafsari R, Hoermann H, Mayatepek E, Kummer S, Meissner T. Risk factors for adverse neurodevelopment in transient or persistent congenital hyperinsulinism. Front Endocrinol (Lausanne). 2020. https:\/\/doi.org\/10.3389\/fendo.2020.580642.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4763_CR5","doi-asserted-by":"publisher","DOI":"10.1053\/siny.2001.0090","author":"P de Lonlay","year":"2002","unstructured":"de Lonlay P, Touati G, Robert JJ, Saudubray JM. Persistent hyperinsulinaemic hypoglycaemia. Semin Neonatol. 2002. https:\/\/doi.org\/10.1053\/siny.2001.0090.","journal-title":"Semin Neonatol"},{"key":"4763_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.03.057","author":"PS Thornton","year":"2015","unstructured":"Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the pediatric Endocrine Society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015. https:\/\/doi.org\/10.1016\/j.jpeds.2015.03.057.","journal-title":"J Pediatr"},{"issue":"3","key":"4763_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1542\/peds.2010-3851","volume":"127","author":"DH Adamkin","year":"2011","unstructured":"Committee on Fetus and Newborn, Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127(3):575\u20139. https:\/\/doi.org\/10.1542\/peds.2010-3851.","journal-title":"Pediatrics"},{"key":"4763_CR8","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.26.127","author":"T Yorifuji","year":"2017","unstructured":"Yorifuji T, Horikawa R, Hasegawa T, Adachi M, Soneda S, Minagawa M, et al. Clinical practice guidelines for congenital hyperinsulinism. Clin Pediatr Endocrinol. 2017. https:\/\/doi.org\/10.1297\/cpe.26.127.","journal-title":"Clin Pediatr Endocrinol"},{"key":"4763_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.03.011","author":"N Schwartz","year":"2015","unstructured":"Schwartz N, Nachum Z, Green MS. The prevalence of gestational diabetes mellitus recurrence\u2013effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol. 2015. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.011.","journal-title":"Am J Obstet Gynecol"},{"key":"4763_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1361","author":"E Vounzoulaki","year":"2020","unstructured":"Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020. https:\/\/doi.org\/10.1136\/bmj.m1361.","journal-title":"BMJ"},{"key":"4763_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107850","author":"S Yasuda","year":"2021","unstructured":"Yasuda S, Inoue K, Iida S, Oikawa Y, Namba A, Isshiki M, et al. Differences in the birthweight of infants born to patients with early- or mid-to-late-detected gestational diabetes mellitus who underwent guideline-based glycemic control. J Diabetes Complications. 2021. https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.107850.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"4763_CR12","doi-asserted-by":"publisher","first-page":"s88","DOI":"10.2337\/diacare.27.2007.s88","volume":"27","author":"American Diabetes Association","year":"2004","unstructured":"American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004;27(1):s88\u201390. https:\/\/doi.org\/10.2337\/diacare.27.2007.s88.","journal-title":"Diabetes Care"},{"key":"4763_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxy025","author":"MP Flavin","year":"2018","unstructured":"Flavin MP, Osiovich H, Coughlin K, Sgro M, Ray J, Hu L, et al. Hypoglycemia in unmonitored full-term newborns-a surveillance study. Paediatr Child Health. 2018. https:\/\/doi.org\/10.1093\/pch\/pxy025.","journal-title":"Paediatr Child Health"},{"key":"4763_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.05.022","author":"DL Harris","year":"2012","unstructured":"Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012. https:\/\/doi.org\/10.1016\/j.jpeds.2012.05.022.","journal-title":"J Pediatr"},{"key":"4763_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011027.pub3","author":"E Taygen","year":"2022","unstructured":"Taygen E, Gordon L, Malcolm B, Harris DL, Hegarty JE, Weston PJ, et al. Oral dextrose gel for the treatment of hypoglycaemia in newborn infants. Cochrane Database Syst Rev. 2022. https:\/\/doi.org\/10.1002\/14651858.CD011027.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"4763_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-312772","author":"PJ Weston","year":"2017","unstructured":"Weston PJ, Harris DL, Harding JE. Dextrose gel treatment does not impair subsequent feeding. Arch Dis Child Fetal Neonatal Ed. 2017. https:\/\/doi.org\/10.1136\/archdischild-2017-312772.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"4763_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1213\/00000539-198201000-00008","volume":"61","author":"J Mendiola","year":"1982","unstructured":"Mendiola J, Grylack LJ, Scanlon JW. Effects of intrapartum maternal glucose infusion on the normal fetus and newborn. Anesth Analg. 1982;61:32\u20135.","journal-title":"Anesth Analg"},{"key":"4763_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijgo.2007.01.016","volume":"97","author":"A Jamal","year":"2007","unstructured":"Jamal A, Choobak N, Tabassomi F. Intrapartum maternal glucose infusion and fetal acid-base status. Int J Gynaecol Obstet. 2007;97:187\u20139.","journal-title":"Int J Gynaecol Obstet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04763-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04763-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04763-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T16:06:58Z","timestamp":1652976418000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04763-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4763"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04763-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"type":"electronic","value":"1471-2393"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient described in the study provided informed consent, and the study design was approved by the appropriate ethics review board. Written informed consent was obtained from the parents of this patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"423"}}